Device Trial Radar · NCT02475200
Phoenix Post-Approval Registry - Using the Phoenix Atherectomy Systems
Last checked: Nov 19, 2026Latest source record: Jun 9, 2020 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
500
Actual
Start
Sep 14, 2015
Primary completion
Apr 8, 2018
Study completion May 29, 2020
Sponsor
- Lead sponsor
- Volcano CorporationNot on our public-company list
- Sponsor type
- Industry
- First posted
- Jun 18, 2015
Design
- Study type
- Observational
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The Phoenix Post-Approval Registry is a prospective, multi-center, single arm registry sponsored by Volcano Corporation to evaluate the short and long term performance and clinical outcomes of the Phoenix Atherectomy System.
Conditions
- Peripheral Arterial Disease
- Claudication
- Critical Limb Ischemia
Interventions
AtherectomyDevice
Selectively cut and remove atheromatous plaque in the lower extremities. Debulking and removal of atherosclerotic burden plaque with Phoenix Atherectomy System.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Phoenix device performanceTime frame: 30 days
Locations
5 sites in 1 country. Site status is shown where the registry gives one.
Pima Vascular
Tucson, Arizona
St. John Hospital
Detroit, Michigan
Mid-Michigan Heart & Vascular Center
Saginaw, Michigan
2 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.